LHLouis Marie Houdebine

Louis Marie Houdebine

*This is an algorithmically generated author record based on publicly available information.

Louis Marie Houdebine has a total of 10 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Les cellules souches : de nouveaux espoirs pour les greffes

    by Louis-Marie Houdebine

    La recherche utilisant des lignées de cellules embryonnaires souches (ES) n’est actuellement pas autorisée. L’utilisation d’embryons surnuméraires conservés à la suite de fécondation in vitro ou obtenus par clonage pose des questions qui dépassent les simples enjeux scientifiques. Louis-Marie Houdebine analyse les différentes techniques de réparation des tissus et souligne l’étendue des progrès à accomplir avant que l’on puisse espérer des résultats bénéfiques pour l’être humain.


  • Animal transgenesis: recent data and perspectives

    by Louis-Marie Houdebine


  • Transgenic animal bioreactors

    by Louis Marie Houdebine

    The production of recombinant proteins is one of the major successes of biotechnology. Animal cells are required to synthesize proteins with the appropriate post-translational modifications....


  • Internal ribosome entry sites (IRESs): reality and use

    by Louis Marie Houdebine, Joe Attal

    IRESs are known to recruit ribosomes directly, without a previous scanning of untranslated region of mRNA by the ribosomes. IRESs have been found in a number of viral and cellular mRNAs....


    • 1 January 1999
      • Vol. 8, 299-309

    Effect of intercistronic length on internal ribosome entry site (IRES) efficiency in bicistronic mRNA.

    by J Attal, M C Theron, C Puissant, L M Houdebine

    Specific structures found in the mRNA of picornavirus are known to allow a cap-independent translation. These structures, named internal ribosome entry sites (IRES), are also able to favor translation of the second cistron in bicistronic mRNAs. Their mechanism of action is not well understood. In the present study, two IRESs have been used: the IRES from poliovirus and a newly discovered IRES (SUR) composed of the 5' P untranslated sequence from SV40 early genes, the R structure, and a small part of the U5 region from the human leukemia virus-1 (HTLV-1). The bicistronic constructs containing the firefly luciferase gene as the first cistron and the chloramphenicol acetyltransferase (CAT) as the second cistron were driven by the Rous sarcoma virus (RSV) promoter and contained the early gene SV40 terminator. All the resulting plasmids were tested by transfection in HeLa and CHO cells. In the bicistronic mRNAs without IRES, the expression of the CAT gene was dependent on the distance between the two cistrons. The maximum efficiency in the expression of the second cistron was obtained when the intercalating RNA was composed of 30 to 90 nucleotides. This expression was deeply reduced when the intercalating fragment contained 8 or 300 nucleotides and was undetectable with 500 nucleotides. Unexpectedly, the luciferase mRNA was almost not expressed when the intercalating RNA was of 8 or 30 nucleotides. Expression of the luciferase gene occurred when the intercistronic RNA fragment was of 80 nucleotides and it became lower at 300 and 500 nucleotides. The same observations were done when the poliovirus or the SUR IRESs were added after the intercistronic spacers. However, expression of the CAT gene was amplified by both IRESs. When the CAT cistron preceded by the poliovirus or SUR IRES was introduced within luciferase cistron, 316 nucleotides before its termination codon, the IRESs were able to initiate translation of the following CAT gene irrespectively of the mRNA luciferase reading frame. Moreover, with all these constructs the highest expression level of the CAT cistron did not exceed 10% of that obtained with the same vector carrying only the CAT cistron. To identify a possible relation between the IRESs and the cap site, the CAT cistron preceded or not with an IRES was introduced 210 nucleotides downstream of the AUG codon of the luciferase gene (i.e., 258 nucleotides from the cap site) and 100 nucleotides after an added UAG termination codon. Expression of the CAT gene was not modified by the addition of the poliovirus IRES but it was strongly stimulated by the SUR IRES (the level of expression corresponded to 65% of that obtained with the same vector carrying only the CAT cistron). These results suggest that there is a cooperation between the cap and the SUR IRES and not the poliovirus IRES to stimulate translation. These data indicate that IRESs must be introduced in precise position to allow an efficient expression of the second cistron in bicistronic mRNAs.


    • 21 September 1996
      • Vol. 25  (27) , 1247-50

    [Applications of transgenesis in xenotransplantation. Experimental results and clinical prospects].

    by B Malassagne, F Tabois, L M Houdebine, J Attal, D Houssin, B Weill

    Transgenesis is now a genetic procedure commonly performed. The first clinical application of transgenesis could be xenografting between distant species such as swine and human. Transgenic expression of human complement regulatory proteins including CD55 and CD59 in pig has already been reported. An alternative strategy aims at reducing the expression of the xenoantigens on the cell surface by knocking out relevant genes through homologous recombination. Preliminary results of xenotransplantation of transgenic organs to macacus have suggested that xenogeneic hyperacute rejection could be overcome. After these recent advances, new attempts of xenotransplantation in human could be performed in a short term, at least as a bridge in the expectation of an allogeneic graft.

    • 1 June 1993
      • Vol. 2  (3) , 181-8

    Efficiency of introns from various origins in fish cells.

    by O H Bétancourt, J Attal, M C Théron, C Puissant, L M Houdebine

    Several vectors containing (1) regulatory regions from Rous sarcoma virus (RSV), human cytomegalovirus (CMV), and herpes simplex thymidine kinase (TK); (2) introns from early or late SV40 genes and from trout growth hormone gene (tGH); (3) chloramphenicol acetyltransferase gene (CAT); and (4) transcription terminators from SV40 were transfected into carp EPC cells, salmon CHSE cells, tilapia TO2 cells, quail QT6 cells, and hamster CHO cells. CAT activity was measured in extracts from several cell lines 3 days after transfection and in the fish EPC stable clones. The CMV and RSV promoters were the most potent in all cell types. The intron from late SV40 genes (VP1 intron) worked properly in QT6 and CHO cells but not in EPC and very weakly in TO2 cells. The tGH intron was efficient in all cell types but preferentially in fish cells. The small t intron from SV40 was processed in all cell types. The small t and, to a lesser extent, the tGH introns amplified expression of cat gene in stable clones, in comparison to the transiently transfected cells. These results indicate that elements from mammalian genes may not be properly recognized by the fish cellular machinery and in an unpredictable manner. This finding suggests that vectors prepared to express foreign genes in transfected cultured fish cells and transgenic fish should preferably contain DNA sequences from fish genes or, alternatively, those sequences from mammalian genes that have been previously proved to be compatible with the fish cellular machinery.


    • 1 March 1990
      • Vol. 8  (3) , 269-71

    An improvement of a rapid method using Qiagen columns to purify plasmids.

    by J Attal, C Puissant, L M Houdebine